Lisdexamfetamine Dimesylate 00480-9739
Product NDC
00480-9739- Manufacturer
- Teva Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Chewable
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 16, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA215415
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 30 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET, CHEWABLE in 1 BOTTLE (0480-9739-01)